Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid cancer, Hurthle cell × Sodium Iodide × Endocrine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Adenocarcinoma, Follicular 1

Interventions

trametinib 1 spartalizumab 1 pembrolizumab 1 motesanib diphosphate 1 lenvatinib 1 gallium Ga 68 dotatate 1 dabrafenib 1 cediranib 1 Sorafenib 1 Sodium Iodide 1 Lenalidomide 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01398085 2024-05-08

IoN

University College, London

Phase 2/3 Active not recruiting

EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡